APA (7th ed.) Citation

Haedersdal, M., Kilov, K., Ortner, V. K., Johansen, B., Mondragón, A. C., Duvold, T., . . . Zibert, J. R. (2022, October). The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A2 inhibitor, AVX001, in participants with actinic keratosis: Protocol for a randomised controlled phase I/IIa trial. BMJ Open.

Chicago Style (17th ed.) Citation

Haedersdal, Merete, et al. "The Copenhagen Actinic Keratosis Study (COAKS). A Decentralised Clinical Trial to Evaluate Tolerability, Safety and Efficacy of Daily Field-directed Topical Treatment with Cytosolic Phospholipase A2 Inhibitor, AVX001, in Participants with Actinic Keratosis: Protocol for a Randomised Controlled Phase I/IIa Trial." BMJ Open Oct. 2022.

MLA (9th ed.) Citation

Haedersdal, Merete, et al. "The Copenhagen Actinic Keratosis Study (COAKS). A Decentralised Clinical Trial to Evaluate Tolerability, Safety and Efficacy of Daily Field-directed Topical Treatment with Cytosolic Phospholipase A2 Inhibitor, AVX001, in Participants with Actinic Keratosis: Protocol for a Randomised Controlled Phase I/IIa Trial." BMJ Open, Oct. 2022.